Vascular vasopressin receptors

General Pharmacology

Volumn 19, Issue 5, 1988, Pages 639-647

  Fox, Anthony W ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PHOSPHATIDYLINOSITOL; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

BLOOD PRESSURE; BLOOD VESSEL; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

ANIMAL; HUMAN; RECEPTORS, ANGIOTENSIN; RECEPTORS, VASOPRESSIN;

EID: 0023813424     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(88)90121-8     Document Type: Short Survey

References (90)

1. Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers
2. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery
3. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line
4. Solubilization and reconstitution of vasopressin V-1 receptors of rat liver
5. Dose response relationships for argvasopressin and synthetic analogues on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal
6. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle.
7. Some quantitative uses of drug antagonists
8. VASOPRESSIN POTENTIATION OF CATECHOLAMINE ACTIONS IN DOG, RAT, CAT, AND RAT AORTIC STRIP.
9. Human platelet vasopressin receptors
10. 3H-lys-vasopressin to pig kidney plasma membranes
11. - cotransport in cultured endothelial cells
12. Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?
13. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension
14. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic effects: effects of highly potent analogues and competitive inhibitors
15. 3H]-vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation
16. 50) of an enzymatic reaction
17. Vasopressin elevation in essential hypertension and increased responsiveness to sodium intake.
18. Determination of the functional molecular size of vasopressin isoreceptors
19. Plasma vasopressin and blood pressure. Studies in normal subjects and in benign essential hypertension at rest and after postural challenge.
20. Vasopressin antagonists block peripheral as well as central vasopressin receptors
21. Inositol phosphates: concord or confusion?
22. Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland.
23. The isolation and proof of structure of the vasopressins and the synthesis of octapeptide amines with pressor-antidiuretic activity
24. Evidence for spare α1-adrenoceptors for the accumulation of inositol phosphates in smooth muscle
25. Non-competitive blockade of vasopressin-1 receptors in rat tail artery
26. 3H]-inositol metabolism in rat tail artery
27. The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes
28. Pharmacological characterization of receptors: its relation to radioligand-binding studies.
29. An oxytocin receptor in anococcygeus muscles isolated from male mice
30. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells.
31. Evidence for two molecular forms of solubilized vasopressin receptors in rat kidney membranes: regulation by guanyl nucleotides
32. A vasopressin-like peptide in the mammalian sympathetic nervous system
33. Agents affecting the renal conservation of water
34. The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I.
35. Vasopressin induced myocardial depression is neurally mediated and not due to impaired coronary blood flow
36. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
37. Les isorecepteurs dela vasopressine dans le foie et dans le rein: relation entre fixation d'hormone et reponse biologique
38. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in rat adenohypophysis
39. Role of vasopressin in cardiovascular homeostasis and hypertension.
40. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery
41. Oxytocin causes endothelium-dependent relaxations of the canine basilar artery by activating V-1 vasopressinergic receptors
42. Receptor classification by selective agonists: coping with circularity and circumstantial evidence
43. The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors
44. The classification of drugs and drug receptors
45. Ligand-receptor interactions: what we can and cannot learn from binding measurements
46. 2)5Tyr(Me)-AVP
47. [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin
48. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
49. Is vasopressin an important hypertensive hormone?
50. [1-(.beta.-Mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),4-valine, 8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin
51. The relationships between receptor binding capacity for norepinephrine, angiotensin II, and vasopressin and release of inositol tris-phosphate, calcium mobilization, and phosphorylase activation in rat liver
52. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin
53. Inositol phospholipids and cell surface receptor function
54. Occupancy of alpha-1 adrenergic receptors and contraction of rat vas deferens
55. Pressor Responsiveness and Cardiovascular Reflex Activity in Spontaneously Hypertensive and Normotensive Rats During Vasopressin Infusion
56. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg]vasopressin in vascular smooth muscle cells.
57. Inositol phospholipid hydrolysis as a primary response to receptors not linked to adenylate cyclase
58. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor induced cyclic 3′5′ AMP accumulation
59. Pharmacological properties of a new adrenergic blocking drug: N,N-dibenzyl, beta-chloro ethylamine (dibenamine)
60. On the physiological action of extracts of pituitary body and certain other glandular organs
61. CHANGES OF VASOPRESSIN IN HYPERTENSION: CAUSE OR EFFECT?
62. Blood Pressure in Acute and Chronic Vasopressin Excess
63. Role of angiotensin II, alpha-adrenergic system, and arginine vasopressin on arterial pressure in rat.
64. Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture.
65. Inositol trisphosphate and the contraction of vascular smooth muscle cells
66. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in hepatocytes by vasopressin.
67. Agonist radioligands for identifying functional neurotransmitter receptors. Introduction.
68. Vasopressin: mechanism of central cardiovascular action in conscious rats
69. Role of Arginine Vasopressin in Regulation of Systemic Arterial Pressure
70. Evolution of antidiuretic hormones and their functions
71. The use of antagonists of vasopressin in studies of its physiological functions.
72. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
73. Activation of vasopressin-1 receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets
74. The role of vasopressin in hypertension.
75. Vascular smooth muscle II: Pharmacology of normal and hypertensive vessels
76. Effect of magnesium on posterior pituitary hormone action on vascular smooth muscle.
77. Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle.
78. Actions of vasopressin antagonists: molecular mechanisms
79. Identification and characterization of vascular (V-1) vasopressin receptors of an established smooth muscle cell line
80. 3H].SK&F 101926
81. A modification of receptor theory
82. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate
83. Clonidine can lower blood pressure by inhibiting vasopressin release
84. Stimulation of inorganic-phosphate incorporation into phosphatidylinositol in rat thoracic aorta mediated through V1-vasopressin receptors.
85. Solubilization of human platelet vasopressin receptors
86. Quantitation and early kinetics of inositol lipid changes induced by vasopressin in isolated and cultured hepatocytes.
87. Stimulation by vasopressin and alpha-catecholamines of phosphatidylinositol formation in isolated rat liver parenchymal cells.
88. Nature and properties of human platelet vasopressin receptors.
89. RELATIVE CONTRIBUTION OF DIFFERENT VASCULAR BEDS TO THE PRESSOR EFFECTS OF α-ADRENORECEPTOR AGONISTS AND VASOPRESSIN IN PITHED RATS: RADIOACTIVE MICROSPHERE DETERMINATION